Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Depreciation & Amortization (CF) (2019 - 2025)

Historic Depreciation & Amortization (CF) for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $661000.0.

  • IDEAYA Biosciences' Depreciation & Amortization (CF) rose 1455.81% to $661000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 437.81%. This contributed to the annual value of $2.4 million for FY2024, which is 359.45% down from last year.
  • According to the latest figures from Q3 2025, IDEAYA Biosciences' Depreciation & Amortization (CF) is $661000.0, which was up 1455.81% from $718000.0 recorded in Q2 2025.
  • IDEAYA Biosciences' Depreciation & Amortization (CF)'s 5-year high stood at $718000.0 during Q2 2025, with a 5-year trough of $382000.0 in Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $577000.0 (2024), whereas its average is $561473.7.
  • In the last 5 years, IDEAYA Biosciences' Depreciation & Amortization (CF) skyrocketed by 3175.07% in 2021 and then tumbled by 984.37% in 2024.
  • IDEAYA Biosciences' Depreciation & Amortization (CF) (Quarter) stood at $448000.0 in 2021, then rose by 24.55% to $558000.0 in 2022, then increased by 12.72% to $629000.0 in 2023, then decreased by 9.06% to $572000.0 in 2024, then grew by 15.56% to $661000.0 in 2025.
  • Its last three reported values are $661000.0 in Q3 2025, $718000.0 for Q2 2025, and $600000.0 during Q1 2025.